Table of Content
1 Study Coverage
1.1 Ophthalmology Biologics Product Introduction
1.2 Market by Type
1.2.1 Global Ophthalmology Biologics Market Size Growth Rate by Type, 2019 VS 2024 VS 2030
1.3 Market by Application
1.3.1 Global Ophthalmology Biologics Market Size Growth Rate by Application, 2019 VS 2024 VS 2030
1.4 Global Ophthalmology Biologics Market by Region
1.4.1 Global Ophthalmology Biologics Market by Region: 2019 VS 2024 VS 2030
1.4.2 Global Ophthalmology Biologics Revenue Market
1.5 Study Objectives
1.6 Years Considered
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global Ophthalmology Biologics Revenue by Players
2.1.1 Global Ophthalmology Biologics Revenue by Players (2019-2024)
2.1.2 Global Ophthalmology Biologics Revenue Market Share by Players (2019-2024)
2.1.3 Global Top 5 and Top 10 Companies by Ophthalmology Biologics Revenue in 2024
2.2 Global Ophthalmology Biologics Gross Margin by Players
2.3 Analysis of Competitive Landscape
2.3.1 Players Market Concentration Ratio (CR5)
2.3.2 Global Ophthalmology Biologics Players Geographical Distribution
2.4 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 Allergan
3.1.1 Allergan Information
3.1.2 Allergan Overview
3.1.3 Allergan Ophthalmology Biologics Revenue and Gross Margin (2019-2024)
3.1.4 Allergan Related Developments
3.2 Bristol-Myers Squibb
3.2.1 Bristol-Myers Squibb Information
3.2.2 Bristol-Myers Squibb Overview
3.2.3 Bristol-Myers Squibb Ophthalmology Biologics Revenue and Gross Margin (2019-2024)
3.2.4 Bristol-Myers Squibb Related Developments
3.3 Genzyme Corporation
3.3.1 Genzyme Corporation Information
3.3.2 Genzyme Corporation Overview
3.3.3 Genzyme Corporation Ophthalmology Biologics Revenue and Gross Margin (2019-2024)
3.3.4 Genzyme Corporation Related Developments
3.4 Ocular Therapeutix
3.4.1 Ocular Therapeutix Information
3.4.2 Ocular Therapeutix Overview
3.4.3 Ocular Therapeutix Ophthalmology Biologics Revenue and Gross Margin (2019-2024)
3.4.4 Ocular Therapeutix Related Developments
3.5 UCBCares
3.5.1 UCBCares Information
3.5.2 UCBCares Overview
3.5.3 UCBCares Ophthalmology Biologics Revenue and Gross Margin (2019-2024)
3.5.4 UCBCares Related Developments
3.6 Alimera Sciences
3.6.1 Alimera Sciences Information
3.6.2 Alimera Sciences Overview
3.6.3 Alimera Sciences Ophthalmology Biologics Revenue and Gross Margin (2019-2024)
3.6.4 Alimera Sciences Related Developments
3.7 Swedish Orphan Biovitrum
3.7.1 Swedish Orphan Biovitrum Information
3.7.2 Swedish Orphan Biovitrum Overview
3.7.3 Swedish Orphan Biovitrum Ophthalmology Biologics Revenue and Gross Margin (2019-2024)
3.7.4 Swedish Orphan Biovitrum Related Developments
3.8 Genentech
3.8.1 Genentech Information
3.8.2 Genentech Overview
3.8.3 Genentech Ophthalmology Biologics Revenue and Gross Margin (2019-2024)
3.8.4 Genentech Related Developments
3.9 F. Hoffmann-La Roche
3.9.1 F. Hoffmann-La Roche Information
3.9.2 F. Hoffmann-La Roche Overview
3.9.3 F. Hoffmann-La Roche Ophthalmology Biologics Revenue and Gross Margin (2019-2024)
3.9.4 F. Hoffmann-La Roche Related Developments
3.10 AbbVie
3.10.1 AbbVie Information
3.10.2 AbbVie Overview
3.10.3 AbbVie Ophthalmology Biologics Revenue and Gross Margin (2019-2024)
3.10.4 AbbVie Related Developments
3.11 Janssen Biotech
3.11.1 Janssen Biotech Information
3.11.2 Janssen Biotech Overview
3.11.3 Janssen Biotech Ophthalmology Biologics Revenue and Gross Margin (2019-2024)
3.11.4 Janssen Biotech Related Developments
3.12 Bausch & Lomb
3.12.1 Bausch & Lomb Information
3.12.2 Bausch & Lomb Overview
3.12.3 Bausch & Lomb Ophthalmology Biologics Revenue and Gross Margin (2019-2024)
3.12.4 Bausch & Lomb Related Developments
4 Global Ophthalmology Biologics Market Insights
4.1 Global Ophthalmology Biologics Market Revenue 2019-2024
4.2 Global Ophthalmology Biologics Revenue by Region
4.3 Americas
4.4 Europe
4.5 Asia-Pacific
4.6 Middle East & Africa
5 Market Size by Type
5.1 Global Ophthalmology Biologics Revenue by Type
5.2 Global Ophthalmology Biologics Market Size Growth by Type 2019-2024
6 Market Size by Application
6.1 Global Ophthalmology Biologics Revenue by Application
6.2 Global Ophthalmology Biologics Market Size Growth by Application 2019-2024
7 Americas
7.1 Americas Ophthalmology Biologics Market Size by Type
7.1.1 Americas Ophthalmology Biologics Revenue by Type (2019-2024)
7.1.2 Americas Ophthalmology Biologics Revenue Share by Type (2019-2024)
7.2 Americas Ophthalmology Biologics Market Size by Application
7.2.1 Americas Ophthalmology Biologics Revenue by Application (2019-2024)
7.2.2 Americas Ophthalmology Biologics Revenue Share by Application (2019-2024)
7.3 Americas Ophthalmology Biologics Market Size by Country
7.3.1 Americas Ophthalmology Biologics Revenue by Country (2019-2024)
7.3.2 U.S.
7.3.3 Canada
7.3.4 Mexico
7.3.5 Brazil
7.3.6 Argentina
8 Europe
8.1 Europe Ophthalmology Biologics Market Size by Type
8.1.1 Europe Ophthalmology Biologics Revenue by Type (2019-2024)
8.1.2 Europe Ophthalmology Biologics Revenue Share by Type (2019-2024)
8.2 Europe Ophthalmology Biologics Market Size by Application
8.2.1 Europe Ophthalmology Biologics Revenue by Application (2019-2024)
8.2.2 Europe Ophthalmology Biologics Revenue Share by Application (2019-2024)
8.3 Europe Ophthalmology Biologics Market Size by Country
8.3.1 Europe Ophthalmology Biologics Revenue by Country (2019-2024)
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
9 Asia Pacific
9.1 Asia Pacific Ophthalmology Biologics Market Size by Type
9.1.1 Asia Pacific Ophthalmology Biologics Revenue by Type (2019-2024)
9.1.2 Asia Pacific Ophthalmology Biologics Revenue Share by Type (2019-2024)
9.2 Asia Pacific Ophthalmology Biologics Market Size by Application
9.2.1 Asia Pacific Ophthalmology Biologics Revenue by Application (2019-2024)
9.2.2 Asia Pacific Ophthalmology Biologics Revenue Share by Application (2019-2024)
9.3 Asia Pacific Ophthalmology Biologics Market Size by Region
9.3.1 Asia Pacific Ophthalmology Biologics Revenue by Region (2019-2024)
9.3.2 China
9.3.3 Japan
9.3.4 South Korea
9.3.5 India
9.3.6 Southeast Asia
9.3.7 Australia
10 Middle East and Africa
10.1 Middle East and Africa Ophthalmology Biologics Market Size by Type
10.1.1 Middle East and Africa Ophthalmology Biologics Revenue by Type (2019-2024)
10.1.2 Middle East and Africa Ophthalmology Biologics Revenue Share by Type (2019-2024)
10.2 Middle East and Africa Ophthalmology Biologics Market Size by Application
10.2.1 Middle East and Africa Ophthalmology Biologics Revenue by Application (2019-2024)
10.2.2 Middle East and Africa Ophthalmology Biologics Revenue Share by Application (2019-2024)
10.3 Middle East and Africa Ophthalmology Biologics Market Size by Country
10.3.1 Middle East and Africa Ophthalmology Biologics Revenue by Country (2019-2024)
10.3.2 Turkey
10.3.3 Saudi Arabia
10.3.4 U.A.E
11 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
11.1 Ophthalmology Biologics Industry Trends
11.2 Ophthalmology Biologics Market Drivers
11.3 Ophthalmology Biologics Market Challenges
11.4 Ophthalmology Biologics Market Restraints
12 Ophthalmology Biologics Forecasted Market Size by Type
12.1 Global Ophthalmology Biologics Forecasted Revenue by Type
12.2 Global Ophthalmology Biologics Forecasted Market Size Growth by Type 2024-2030
13 Ophthalmology Biologics Forecasted Market Size by Application
13.1 Global Ophthalmology Biologics Forecasted Revenue by Application
13.2 Global Ophthalmology Biologics Forecasted Market Size Growth by Application 2024-2030
14 Global Ophthalmology Biologics Market Forecasts
14.1 Global Ophthalmology Biologics Market Revenue Forecasts 2024-2030
14.2 Global Ophthalmology Biologics Forecasts Revenue by Region
14.3 Americas
14.4 Europe
14.5 Asia-Pacific
14.6 Middle East & Africa
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer